EP 3253797 A4 20181003 - CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF
Title (en)
CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF
Title (de)
CHEMOKIN-IMMUNOGLOBULIN-FUSIONSPOLYPEPTIDE, ZUSAMMENSETZUNGEN DARAUS, VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON
Title (fr)
POLYPEPTIDES DE FUSION CHIMIOKINE-IMMUNOGLOBULINE, COMPOSITIONS, PROCÉDÉ DE FABRICATION ET UTILISATION ASSOCIÉS
Publication
Application
Priority
- US 201514612884 A 20150203
- US 2016016191 W 20160202
Abstract (en)
[origin: WO2016126719A1] This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
IPC 8 full level
A61K 39/395 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
C07K 14/521 (2013.01); C07K 2319/30 (2013.01)
Citation (search report)
- [X] US 2012308565 A1 20121206 - LILLARD JR JAMES W [US]
- [X] US 2013323245 A1 20131205 - LILLARD JR JAMES W [US]
- [X] US 2013330337 A1 20131212 - LILLARD JR JAMES W [US]
- [A] US 2010196406 A1 20100805 - KARIN NATHAN [IL], et al
- [A] US 2007036750 A1 20070215 - CHOU CHUAN-CHU [US], et al
- [A] WO 2005037305 A1 20050428 - APPLIED RESEARCH SYSTEMS, et al
- See references of WO 2016126719A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2016126719 A1 20160811; CN 107207603 A 20170926; EP 3253797 A1 20171213; EP 3253797 A4 20181003
DOCDB simple family (application)
US 2016016191 W 20160202; CN 201680007087 A 20160202; EP 16747125 A 20160202